Unknown

Dataset Information

0

Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy.


ABSTRACT: Arrhythmogenic Cardiomyopathy (ACM) is characterized by the replacement of the myocardium with fibrotic or fibro-fatty tissue and inflammatory infiltrates in the heart. To date, while ACM adipogenesis is a well-investigated differentiation program, ACM-related fibrosis remains a scientific gap of knowledge. In this study, we analyze the fibrotic process occurring during ACM pathogenesis focusing on the role of cardiac mesenchymal stromal cells (C-MSC) as a source of myofibroblasts. We performed the ex vivo studies on plasma and right ventricular endomyocardial bioptic samples collected from ACM patients and healthy control donors (HC). In vitro studies were performed on C-MSC isolated from endomyocardial biopsies of both groups. Our results revealed that circulating TGF-β1 levels are significantly higher in the ACM cohort than in HC. Accordingly, fibrotic markers are increased in ACM patient-derived cardiac biopsies compared to HC ones. This difference is not evident in isolated C-MSC. Nevertheless, ACM C-MSC are more responsive than HC ones to TGF-β1 treatment, in terms of pro-fibrotic differentiation and higher activation of the SMAD2/3 signaling pathway. These results provide the novel evidence that C-MSC are a source of myofibroblasts and participate in ACM fibrotic remodeling, being highly responsive to ACM-characteristic excess TGF-β1.

SUBMITTER: Maione AS 

PROVIDER: S-EPMC7961797 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy.

Maione Angela Serena AS   Stadiotti Ilaria I   Pilato Chiara Assunta CA   Perrucci Gianluca Lorenzo GL   Saverio Valentina V   Catto Valentina V   Vettor Giulia G   Casella Michela M   Guarino Anna A   Polvani Gianluca G   Pompilio Giulio G   Sommariva Elena E  

International journal of molecular sciences 20210306 5


Arrhythmogenic Cardiomyopathy (ACM) is characterized by the replacement of the myocardium with fibrotic or fibro-fatty tissue and inflammatory infiltrates in the heart. To date, while ACM adipogenesis is a well-investigated differentiation program, ACM-related fibrosis remains a scientific gap of knowledge. In this study, we analyze the fibrotic process occurring during ACM pathogenesis focusing on the role of cardiac mesenchymal stromal cells (C-MSC) as a source of myofibroblasts. We performed  ...[more]

Similar Datasets

| S-EPMC11373413 | biostudies-literature
| S-EPMC7366401 | biostudies-literature
| S-EPMC7286080 | biostudies-literature
| S-EPMC6933341 | biostudies-literature
| S-EPMC8629962 | biostudies-literature
| S-EPMC8122664 | biostudies-literature
| S-EPMC4912024 | biostudies-literature
2021-06-20 | GSE152747 | GEO
| S-EPMC4818879 | biostudies-literature
| S-EPMC5798290 | biostudies-literature